Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V V Fomin

Showing results (21-30 of 204) with videos related to

Pageof 21
Sort By:
Terapevticheskii Arkhiv|August 5, 2016
[Difficulties in correcting hyperphosphatemia in patients with chronic renal failure. A place of noncalcium-containing phosphate-binding drugs]Yu S Milovanov, V V Fomin, L Yu Milovanova
Terapevticheskii Arkhiv|December 6, 2022
[Circulating microRNAs as potential biomarkers of chronic kidney disease]K A Aitbaev, I T Murkamilov, V V Fomin
Kardiologiia|May 22, 2018
[Predictive significance of disturbed water-salt homeostasis in decompensated chronic heart failure patients]K S Fazulina, V V Fomin, V V Meshalkina
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|March 15, 2011
[Reduced glomerular filtration rate as a marker of cardiovascular risk in the general population]N A Mukhin, S V Moiseev, V V Fomin
Terapevticheskii Arkhiv|December 25, 2007
[High risk arterial hypertension: the role of angiotensin II receptor blockers]V V Fomin, S V Moiseev, N A Mukhin
Klinicheskaia Meditsina|October 13, 2005
[Contemporary drug therapy: dramatic dangers and the optimism of ability]N A Mukhin, S V Moiseev, V V Fomin
Terapevticheskii Arkhiv|February 14, 2007
[Evolution of the ideas about arterial hypertension in the papers of E.M. Tareev]N A Mukhin, S V Moiseev, V V Fomin
Kardiologiia|March 12, 2019
K A Aitbaev, I T Murkamilov, V V Fomin
Klinicheskaia Meditsina|August 28, 2001
[Hyperhomocysteinemia as a risk factor for cardiovascular disease]N A Mukhin, S V Moiseev, V V Fomin
Terapevticheskii Arkhiv|July 27, 2011
[Hyperuricemia as a component of cardiorenal syndrome]N A Mukhin, V V Fomin, M V Lebedeva
Pageof 21

Showing results (21-30 of 204) with videos related to

Sort By:
Pageof 21
Terapevticheskii Arkhiv|August 5, 2016
[Difficulties in correcting hyperphosphatemia in patients with chronic renal failure. A place of noncalcium-containing phosphate-binding drugs]Yu S Milovanov, V V Fomin, L Yu Milovanova
Terapevticheskii Arkhiv|December 6, 2022
[Circulating microRNAs as potential biomarkers of chronic kidney disease]K A Aitbaev, I T Murkamilov, V V Fomin
Kardiologiia|May 22, 2018
[Predictive significance of disturbed water-salt homeostasis in decompensated chronic heart failure patients]K S Fazulina, V V Fomin, V V Meshalkina
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|March 15, 2011
[Reduced glomerular filtration rate as a marker of cardiovascular risk in the general population]N A Mukhin, S V Moiseev, V V Fomin
Terapevticheskii Arkhiv|December 25, 2007
[High risk arterial hypertension: the role of angiotensin II receptor blockers]V V Fomin, S V Moiseev, N A Mukhin
Klinicheskaia Meditsina|October 13, 2005
[Contemporary drug therapy: dramatic dangers and the optimism of ability]N A Mukhin, S V Moiseev, V V Fomin
Terapevticheskii Arkhiv|February 14, 2007
[Evolution of the ideas about arterial hypertension in the papers of E.M. Tareev]N A Mukhin, S V Moiseev, V V Fomin
Kardiologiia|March 12, 2019
K A Aitbaev, I T Murkamilov, V V Fomin
Klinicheskaia Meditsina|August 28, 2001
[Hyperhomocysteinemia as a risk factor for cardiovascular disease]N A Mukhin, S V Moiseev, V V Fomin
Terapevticheskii Arkhiv|July 27, 2011
[Hyperuricemia as a component of cardiorenal syndrome]N A Mukhin, V V Fomin, M V Lebedeva
Pageof 21